Non-dilutive $7.45M Phase III SBIR Temporary Vascular Occlusion Clamp (TVOC) contract to commercialize innovative technology targeting hemorrhage control for the U.S. Air Force. CAMBRIDGE, Mass., Oct. 2, 2024 /PRNewswire/ — Amsel Medical Corporation today announces that it has been…
